Doxorubicin Hydrochloride — 20MG, Injection, Suspension, Liposomal, carton of 1 × 10 mL vial

Doxorubicin Hydrochloride — 20MG, Injection, Suspension, Liposomal, carton of 1 × 10 mL vial

Doxorubicin Hydrochloride is a injection, suspension, liposomal for intravenous use. Doxorubicin hydrochloride liposome injection is an anthracycline topoisomerase inhibitor indicated for: Ovarian cancer: After failure of platinum-based chemotherapy ( 1.1 ) AIDS-related Kaposi's Sarcoma: After failure of prior systemic chemotherapy or intolerance to such therapy ( 1.2 ). Multiple Myeloma: In combination with bortezomib in patients who have not previously received bortezomib and have received at least one prior therapy ( 1.3 ).

• Active ingredient or product type: DOXORUBICIN HYDROCHLORIDE
• Strength/concentration: 20MG
• Dosage form and route: Injection, Suspension, Liposomal, Intravenous
• Exact package presentation: carton of 1 × 10 mL vial
• NDC/item number: 70748-339-01
• Manufacturer: LUPIN PHARMA
• Storage/handling: Refrigerate unopened vials of doxorubicin hydrochloride liposome injection at 2°C to 8°C (36°F to 46°F). Do not freeze. Discard unused portion.
• Status: Rx only

Important safety information: Hand-Foot Syndrome may occur.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.